These results suggest a model where SE-induced over-expression of RARα results in an unbalanced excess of unliganded RARα, favoring the more repressive control of the myeloid differentiation program, as the PML-RARA fusion protein does in APL. The gene discussed is PML; the disease is acute promyelocytic leukemia.